Abbott
Noah Lermer possesses extensive experience in regulatory affairs and scientific research, holding positions such as Director of Regulatory Affairs for Abbott, Nanosphere, and as a Professor of Chemistry at Okanagan College. Additional roles include Senior R&D Manager at Life Technologies and Principal Scientist at Roche Diagnostics. Noah Lermer earned a Ph.D. in Physical Chemistry from The University of British Columbia, completing the program between 1989 and 2005.
This person is not in any offices
Abbott
372 followers
Abbott is a healthcare company that develops products to improve quality of life at all stages. Abbott’s portfolio includes diagnostics, medical devices, nutritionals and branded generic medicines. They have over 110,000 employees globally with customers in over 160 countries worldwide. With 130 years of history, Abbott is an established presence in the healthcare industry. Abbott’s portfolio has products targeted towards several categories, including cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines. Some of Abbott’s best known brands include: Similac, a line of infant formulas; EleCare, a nutritionally complete, amino acid-based medical good and infant formula with iron; PediaSure, balanced nutrition for kids on the go; Pedialyte, a formulation to prevent dehydration by restoring lost minerals and nutrients; Ensure, a line of nutrition products supporting active lifestyles; FreeStyle, a glucose monitor to make managing diabetes easier and more convenient; FreeStyle Libre, a handheld reader with a small sensor that continuously monitors glucose levels, eliminating routine finger sticks; and Glucerna, specialized nutrition to help maintain health blood glucose levels and manage diabetes.